Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Alex Keown, BioSpace.com Breaking… Source: BioSpace You Might Also Like Shire to Consolidate 3,000+ Jobs Over 4 Years to 2 Massachusetts Sites June 29, 2017 Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017 Ex-Genentech Employees' Denali Breaks 2017 IPO Records, Raises $250M December 7, 2017
Oxford Immunotec Schedules First Quarter 2017 Earnings Release And Conference Call For May 2, 2017 April 19, 2017
